Assam hospital to be selected for Phase-II trials of Covaxin?



Assam Health Minister Himanta Biswa Sarma said on Friday that Gauhati Medical College and Hospital (GMCH) is likely to be selected as one of the centres for Phase-II trial of "Covaxin", the country's first indigenous vaccine.

"It is almost 99 per cent sure that GMCH will participate (in Phase-II trials)," Sarma added.

'Covaxin" is a joint effort put in by Bharat Biotech in collaboration with Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).

The Health Minister also said that at present, paperwork is going on between Bharat Biotech and Gauhati Medical College and Hospital (GMCH) to streamline the process.